Researchers from prominent oncology research institutions, including Dana-Farber Cancer Institute and Duke University, have partnered with Pattern Health to accelerate their research into improving the lives of cancer patients.
Cancer is among the leading causes of death and suffering worldwide, and correspondingly, the disease area is one of the most researched subjects globally. Research institutions and life science organizations are investing at unprecedented rates in the pursuit of new medicines and therapies for cancer patients, with more than $50 billion invested in oncology research and development (R&D) annually.
While life science organizations focus their efforts on developing new diagnostics and drugs, academic researchers explore the use of emerging technologies and interventions to reduce suffering and improve symptom management. Across both fronts, innovative clinical trial technologies have surged to prominence, promising more rapid, inclusive, and cost-effective research. Clinical trial technologies enable hybrid and decentralized clinical trials (DCT), meaning studies that conduct some or all research activities outside of traditional research sites. These remote research models are particularly impactful in the oncology arena as cancer is common in rural and elderly communities that may have long or arduous journeys to attend appointments at specialty clinics. Global oncology R&D has shifted heavily towards hybrid and decentralized research approaches over recent years, and 80-90% of global clinical trials are anticipated to be fully decentralized or hybrid in the next 5 years.
Pattern Health’s unique Clinical Trial Solution provides a seamless solution for oncology research, including support for DCT and hybrid studies of any scale. Their purpose-built platform makes it easy for research teams to create engaging patient experiences that improve trial participation and efficiency while reducing burden for everyone involved. Pattern delivers industry-leading patient engagement capabilities powered by behavioral science best practices, intuitive consumer-grade user interfaces, and automated workflows. Their platform supports trials end-to-end with features such as digital screening and onboarding, televisits, electronic clinical outcome assessments (eCOA), data collection through connected devices, medication adherence, and more–all accessible at a patient’s convenience on mobile devices.
“We’ve found that patient retention and adherence are key challenges faced by all organizations conducting clinical trials, and particularly those developing oncology therapies and interventions. The average trial suffers from a 30% dropout rate, which can equate to millions in sunk costs. We developed our technology around solving for these industry pain points. Our goal is to make it easier for patients to participate in clinical trials,” explains Pattern Health CEO, Ed Barber.
A growing network of prominent oncology researchers from leading research institutions have partnered with Pattern to accelerate research cycles. Fast and efficient research enables the more rapid delivery of therapeutics to patients, an optimized return on R&D investment, and the ability for academic researchers to capture more grant funding and conduct more concurrent studies. Pattern’s partnerships include researchers from Duke University and Dana-Farber Cancer Institute. Noteworthy clinical trials powered by Pattern include:
mCOPE (mHealth Symptom Management Intervention for Colorectal Cancer Patients)
The mCOPE study is an innovative mobile health coping skills training protocol that is adapted to meet the multiple symptom needs and stage-of-life challenges faced by young and middle-aged adults with cancer. Led by Principal Investigator Sarah A Kelleher, PhD of Duke University.
YES (Young, Empowered & Strong)
The YES study is being done to monitor common symptoms and behavior, and to provide information and peer support, as well as research opportunities for young women who have been diagnosed with breast cancer. Led by Principle Investigator Ann H Partridge, MD, MPH of Dana-Farber Cancer Institute.
ICAN-NC (mHealth Behavioral Cancer Pain Intervention for Medically Underserved Patients)
The ICAN-NC study is evaluating the efficacy of remote therapy sessions and a supplemental app for breast cancer patients in rural areas. The digital health intervention, powered by Pattern, provides participants with symptom tracking and cognitive behavioral coping tools to help reduce pain, fatigue, and distress. Led by Principal Investigator Tamara Somers, PhD, of Duke University.
“We enjoy working with Pattern because they have deep expertise supporting randomized controlled trials and digital health interventions, and they speak our language. Pattern’s configurable platform is key to helping us move quickly with multiple complex studies,” notes Tamara Somers, PhD, Principal Investigator of ICAN-NC.
Organizations interested in learning more about Pattern’s clinical trial capabilities can contact the organization at https://greenlighthealth.com/contact-us/.
About Pattern Health
Pattern Health powers clinical trials and digital interventions for many of the world’s leading academic researchers, CROs, and life science organizations. Our platform offers a wide range of features that help researchers collect data and engage participants. Our unique combination of no-code configuration tools, integration capabilities, supporting services, and catalog of clinical outcomes assessments enable high-quality and efficient research.
To learn more, visit https://greenlighthealth.com/.
